#National Institutes of Health

Using machine learning, researchers find patterns in electronic health record data to better identify those likely to have the condition.

The quick spread of the BA.2 subvariant is likely due to its greater infectiousness rather than its ability to evade the immune system.

NIAID is preparing for the possibility of future variants evading protection against currently available COVID-19 vaccines.

The benefits of achieving herd immunity thresholds have been less successful with respiratory viruses that continually mutate.

Type 2 diabetes is more common among Black Americans and Latinos. Diabetes Alert Day highlights the seriousness and risks.

Studies found that COVID-19 vaccines elicit T cells that recognize the Omicron variant despite the many mutations in its spike protein.

Infection with EBV dramatically increased the odds of developing multiple sclerosis, suggesting vaccines could help prevent it.

Organ transplant recipients take immunosuppressive drugs that impair immune response to pathogens and vaccines.

An NIH-sponsored study assessed boosters for adults fully vaccinated with any authorized or approved COVID-19 vaccine.

A chronic bacterial infection, a flame retardant, and six water disinfection byproducts are listed in a new HHS cancer report.

NIH-supported research will track effects of coronavirus infection on children over three years.

The findings suggest boosters not only lengthen immunity but help broaden and strengthen the immune response.

Collins has led the NIH under three presidents over more than 12 years.

The removal of “AIDS” from the names of two CDC HIV agencies coincides with structural changes.

The NIH awarded nearly $470 million to build a national study population of diverse research volunteers.

About half of people hospitalized with COVID-19 had antibodies that could mistakenly attack the body’s own proteins and tissues.